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ology of which has only recently been revealed following the identification of several novel arenaviruses
in diseased snakes. BIBD-associated arenaviruses (BIBDAV) are genetically divergent from the classi-
cal Old and New World arenaviruses and also differ substantially from each other. Even though there
is convincing evidence that BIBDAV are indeed the etiological agent of BIBD, the BIBDAV reservoir
hosts-if any exist besides boid snakes themselves-are not yet known. In this report, we use University of
Helsinki virus (UHV; a virus that we isolated from a Boa constrictor with BIBD) to show that BIBDAV
can also replicate effectively in mammalian cells, including human cells, provided they are cultured at
30°C. The infection induces the formation of cytoplasmic inclusion bodies (IB), comprised mainly of viral
nucleoprotein (NP), similar to those observed in BIBD and in boid cell cultures. Transferring infected
cells from 30°C to 37°C ambient temperature resulted in progressive declines in IB formation and in the
amounts of viral NP and RNA, suggesting that BIBDAV growth is limited at 37°C. These observations
indirectly indicate that IB formation is linked to viral replication. In addition to mammalian and rep-
tilian cells, UHV infected arthropod (tick) cells when grown at 30°C. Even though our findings suggest
that BIBDAV have a high potential to cross the species barrier, their inefficient growth at mammalian
body temperatures indicates that the reservoir hosts of BIBDAV are likely species with a lower body tem-
perature, such as snakes. IMPORTANCE The newly discovered boid inclusion body disease-associated
arenaviruses (BIBDAV) of reptiles have drastically altered the phylogeny of the family Arenavirus. Prior
to their discovery, known arenaviruses were considered mainly rodent-borne viruses, with each arenavirus
species having its own reservoir host. BIBDAV have so far been demonstrated in captive boid snakes, but
their possible reservoir host(s) have not yet been identified. Here we show, using University of Helsinki
virus as a model, that these viruses are able to infect mammalian (including human) and arthropod cells.
Our results provide in vitro proof of the considerable ability of arenaviruses to cross species barriers.
However, our data indicate that BIBDAV growth occurs at 30°C but is inhibited at 37°C, implying that
crossing of the species barrier would be hindered by the body temperature of mammalian species.
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ABSTRACT 
Boid inclusion body disease (BIDB) is a fatal disease of boid snakes, the etiology of 1 
which has only recently been revealed following identification of several novel 2 
arenaviruses in diseased snakes. BIBD-associated arenaviruses (BIBDAV) are 3 
genetically divergent from the “classical” Old and New World arenaviruses and also 4 
differ substantially from each other. Even though there is convincing evidence that 5 
BIBDAV are indeed the etiological agent of BIBD, the BIBDAV reservoir hosts – if 6 
any exist besides boid snakes themselves – are not yet known. In this report we use 7 
University of Helsinki virus (UHV) to show that BIBDAV can effectively replicate 8 
also in mammalian, including human cells provided they are cultured at 30°C. The 9 
infection induces the formation of cytoplasmic inclusion bodies (IB), comprised 10 
mainly of viral nucleoprotein (NP), similar to those observed in BIBD and in boid cell 11 
cultures. Transfer of infected cells from 30°C to 37°C ambient temperature resulted in 12 
a progressive decline in IB formation and in the amount of viral NP and RNA, 13 
suggesting that BIBDAV growth is limited at 37°C. These observations indirectly 14 
indicate that IB formation is linked to viral replication. In addition to mammalian and 15 
reptilian cells, UHV infected arthropod (tick) cells when grown at 30°C. Even though 16 
our findings suggest that BIBDAV have a high potential to cross the species barrier, 17 
their inefficient growth at mammalian body temperatures indicates that the reservoir 18 
hosts of BIBDAV are likely species with a lower body temperature such as snakes.  19 
  20 
IMPORTANCE 21 
The newly-discovered boid inclusion body disease-associated arenaviruses 22 
(BIBDAV) of reptiles have drastically altered the phylogeny of the family Arenavirus. 23 
Prior to their discovery, known arenaviruses were considered as mainly rodent-borne 24 
viruses, with each arenavirus species having its own reservoir host. BIBDAV have so 25 
far been demonstrated in captive boid snakes but their possible reservoir host(s) have 26 
not yet been identified. Here we show, using University of Helsinki virus as a model, 27 
that these viruses are able to infect mammalian (including human) and arthropod 28 
cells. Our results provide in vitro proof of the considerable ability of arenaviruses to 29 
cross species barrier. However, our data indicate BIBDAV growth occurs at 30˚C but 30 
is inhibited at 37˚C, implying that crossing of the species barrier would be hindered 31 
by the body temperature of mammalian species.  32 
33 
INTRODUCTION 34 
Arenavirus is the genus in the family Arenaviridae, RNA viruses that have earlier 35 
been described as almost exclusively rodent-borne (1). Several arenaviruses are 36 
known to be able to cross the species barrier, for instance to be transmitted from a 37 
rodent host to humans (2-4). Such cross-species transmission often leads to severe 38 
infections which manifest as hemorrhagic fever (Lassa, Guanarito, Junin, Lujo, 39 
Machupo, Sabia or Whitewater Arroyo virus) or meningitis (lymphocytic 40 
choriomeningitis virus, LCMV) in humans (1, 5, 6). While these are usually dead-end 41 
events for the virus, they can occasionally lead to prolonged transmission chains 42 
between humans (7). More recently, several arenaviruses have been detected in 43 
snakes with boid inclusion body disease (BIBD) (8-10), and in vitro experiments, 44 
together with statistical associations, provided convincing evidence of an etiological 45 
relationship between BIBD and arenavirus infection (10). The pathomorphology of 46 
BIBD is manifested by the development of typical eosinophilic intracytoplasmic 47 
inclusion bodies (IB) in almost all cell types of affected animals (10-12). The IB 48 
consist predominantly, if not entirely, of a 68-kDa protein (11) that has recently been 49 
identified as the arenavirus nucleoprotein (NP) (10). They most likely represent 50 
complexes required for arenavirus replication (13).  51 
Arenaviruses have a bi-segmented genome with ambisense coding strategy (14). The 52 
L segment encodes the RNA-dependent RNA polymerase (RdRp) and the Z protein, 53 
and the S segment encodes the glycoprotein precursor (GPC) and the NP (14). Of 54 
these, the RdRp is considered the most conserved, whereas all other structural 55 
proteins exhibit a relatively high variability (14, 15). BIBD-associated arenaviruses 56 
(BIBDAV) show very high genome variability, particularly in the GPC region (8-10, 57 
16, 17). This may reflect differences between reservoir hosts of the viruses (17), since 58 
the glycoproteins encoded in the GPC mediate binding of the virions to the cellular 59 
receptor(s) (18).   60 
To evaluate the potential of BIBDAV to cross species barriers and to shed some light 61 
on the potential reservoir hosts of these viruses, we screened a range of vertebrate and 62 
arthropod cell lines for their susceptibility to the University of Helsinki virus (UHV), 63 
a virus that we isolated from a Boa constrictor with BIBD (10). We also studied the 64 
effect of temperature on the growth of BIBDAV, since we earlier observed productive 65 
UHV infection in Vero E6 cells only when grown at 27-30˚C (10).  66 
67 
MATERIALS AND METHODS 68 
Viruses and cell lines. 69 
UHV propagated in the boid kidney cells (described in (10)), named I/1Ki, used in 70 
this study was purified by density gradient ultracentrifugation as described (19) and 71 
stored at -70˚C (supplemented with bovine serum albumin, BSA) until used for 72 
inoculation. The purified UHV (GenBank accession numbers: KF297881.1 and 73 
KF297880.1) was initially used to infect Vero E6 cells (10), and adaptation to Vero 74 
E6 cells was enhanced by three consecutive passages (a fresh batch of Vero E6 cells 75 
was infected each time with supernatant collected 12-15 days post infection (dpi)). A 76 
second BIBDAV isolate, T10404 (from snake no. 5 in (10), GenBank accession 77 
number KF564801), was passaged once in the boid kidney cells, concentrated, 78 
purified, and stored as described above.  79 
African green monkey kidney (Vero and Vero E6, both from ATCC), human lung 80 
adenocarcinoma (A549, from ATCC), baby hamster kidney (BHK-21, from ATCC) 81 
and Boa constrictor kidney (I/1Ki, described in (10)) cells were cultured in Basal 82 
Medium Eagle (BME; Biochrom) containing 10% tryptose phosphate broth (TPB; 83 
Difco, Sigma-Aldrich), 15 mM HEPES, 2 mM L-glutamine, 10 μg/ml gentamicin, 84 
and 50 IU/ml nystatin (Valeant Pharmaceuticals), pH 7.2 to 7.3 when used for 85 
infections with UHV purified from boid cells, and were cultured in Minimal Essential 86 
Medium (MEM, Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS), 87 
25 mM HEPES, 2 mM L-glutamine, 100 IU/ml penicillin, and 100 μg/ml 88 
streptomycin when used for infections with UHV purified from Vero E6 cells and 89 
infections with T10404. When studying the effect of a temperature switch on 90 
BIBDAV growth in vertebrate cells, both infected and non-infected cells were 91 
maintained at either 30°C or 37°C for 4 to 5 d after virus inoculation, after which half 92 
of each group of cells at each temperature, infected and non-infected, were transferred 93 
to the opposite temperature, i.e. cells grown at 30°C were maintained at 37°C and vice 94 
versa. For western blotting and RT-PCR, cell samples were collected at 1-2 d 95 
intervals, and samples for other assays (histology and immunohistochemistry) were 96 
collected 4 d after the temperature swap. Cells maintained at 30°C or 37°C for the 97 
entire experimental period served as controls. 98 
Three tick embryo-derived cell lines, the Ixodes ricinus cell line IRE/CTVM19 (20, 99 
21), the Rhipicephalus (Boophilus) microplus cell line BME/CTVM2 (22) and the 100 
Rhipicephalus appendiculatus cell line RAE/CTVM1 (22) were maintained in 2 ml L-101 
15 (Leibovitz) medium (Sigma-Aldrich) supplemented with 20% FBS, 10% TPB, 2 102 
mM L-glutamine, 100 IU/ml penicillin, and 100 μg/ml streptomycin in sealed flat-103 
sided culture tubes (Nunc) at 30°C. Medium was changed weekly by removal and 104 
replacement of ¾ of the medium volume and resuspended cells were subcultured 1:1 105 
when required (20). Infection of tick cells was done by adding UHV propagated in 106 
boid cells and purified by density gradient ultracentrifugation to the culture medium, 107 
followed by 14 d incubation at 30°C.  108 
Cloning, production and purification of recombinant UHV proteins. 109 
Partial S segment of UHV cloned (10) into pGEM-T vector (Promega) was used as 110 
the template for PCR cloning of full length (rNP, amino acids 1-582) as well as N- 111 
(rNP-N, amino acids 1-339) and C-terminal (rNP-C, amino acids 346-582) portions of 112 
the UHV NP. These regions were chosen based on both the knowledge of functional 113 
domains (23) and the structural data of arenavirus NP (24). PCR cloning of the 114 
fragments was accomplished using Phusion High-Fidelity DNA polymerase (Thermo 115 
Scientific) with the following primers for NP: 5'-116 
GGTACCATGGCTGCACTACAAAGAGC-3' and 5'-117 
CTCGAGGACCTCCACAGGCC-3'; N-term NP: 5'-118 
GGTACCATGGCTGCACTACAAAGAGC-3' and 5'-119 
CTCGAGCCTTCTCAAACGGAATACCG-3'; C-term NP: 5'-120 
CATATGAGGTTATACCCGGACTTGATGGA-3'  and 5'-121 
CTCGAGGACCTCCACAGGCC-3'. The cloning and production of recombinant 122 
bacmids was done following the Bac-to-Bac HBM TOPO Secreted expression system 123 
manual (Life Technologies). P1 supernatants containing recombinant baculoviruses 124 
were harvested 4 to 7 days after transfecting Sf9 cells with purified recombinant 125 
bacmids.   126 
For recombinant protein production, confluent High Five cells (75 cm2 bottle) were 127 
detached with a cell scraper and pelleted by centrifugation (500 x g, 5 min, RT). The 128 
cell pellets were suspended in 1 ml of cell culture supernatant containing recombinant 129 
baculoviruses, incubated for 1 h at room temperature (RT), and transferred into two 130 
175 cm2 bottles to which 25 ml growth medium were added. The cells were collected 131 
between 5 and 7 dpi. 132 
The recombinant proteins were purified from cells infected with recombinant 133 
baculovirus as follows: the cell pellet was suspended in 3 ml lysis buffer 1 (50 mM 134 
Tris, pH 7.5), and the cell suspension centrifuged (4,000 x g, 10 min, RT). The 135 
resultant pellet (containing the insoluble recombinant protein) was suspended in 5 ml 136 
lysis buffer 1 and centrifuged as above. The resultant pellet was suspended in 5 ml 137 
lysis buffer 2 (50 mM Tris, 150 mM NaCl, 0.1% Triton X-100, pH 7.5) and 138 
centrifuged (4,000 x g, 30 min, 4˚C); the procedure was repeated once. After washes 139 
with lysis buffer 2 the resultant pellet was suspended in 2 ml lysis buffer 3 (50 mM 140 
Tris, 500 mM NaCl, 1% Triton X-100, pH 7.5) and centrifuged (16,000 x g, 5 min, 141 
RT). The washing was repeated once using 3 ml lysis buffer 3. The resultant pellet 142 
was homogenized in 9 ml binding buffer (50 mM Tris, 500 mM NaCl, 6 M guanidine-143 
HCl, pH 8.0) by passing several times through an 18G needle on a 5 ml syringe. One 144 
ml of Ni-NTA agarose beads (Invitrogen) equilibrated in binding buffer was added to 145 
the cell homogenate, followed by 1 h incubation at RT. The beads were washed 3 146 
times with binding buffer (500 x g, 3 min, RT, centrifugations), and the recombinant 147 
proteins were eluted by addition of 1 ml elution buffer (50 mM Tris, 500 mM NaCl, 6 148 
M Guanidine-HCl, 500 mM Imidazole, pH 8.0) and centrifugation 500 x g, (3 min, 149 
RT). The elution was repeated three times. Concentration and buffer exchange (to 35 150 
mM HEPES, 135 mM NaCl, 1 M guanidine-HCL, pH 8.2) of the recombinant 151 
proteins was done using a centrifugal filter device with 10 kDa cut-off (Millipore). 152 
For SDS-PAGE analysis, guanidine was removed with ethanol (1 part protein solution 153 
+ 9 parts ethanol) precipitation (30 min at -70˚C, centrifugation at 16,000 x g for 10 154 
min at 4˚C).  155 
Antibodies. 156 
Purified rNP-N and rNP-C were used to produce polyclonal antisera, similarly to 157 
those described in (10), by BioGenes GmbH, but with initial injections of 150 μg, 70 158 
μg boosters on days 7 and 14, 150 μg boosters on day 28, and 70 μg boosters on day 159 
42. A previously prepared rabbit antiserum against purified and lysed UHV (10), and 160 
the antisera produced against rNP-N and rNP-C were affinity purified by rNP coupled 161 
to CnBr activated Sepharose (GE Healthcare) according to the manufacturer’s 162 
protocol. The affinity purified rNP-N and rNP-C polyclonal antibodies (PAb) were 163 
labeled with horseradish peroxidase (HRP) using the EZ-Link Activated Peroxidase 164 
Antibody Labeling Kit (ThermoScientific) as instructed by the manual.  165 
SDS-PAGE and immunoblotting. 166 
Protein separations by SDS-PAGE (8 to 12% gels) and wet blotting of proteins onto 167 
nitrocellulose (Whatman) were done according to standard protocols. The protein 168 
concentrations of cell lysates (in 50 mM Tris, 150 mM NaCl, 1% Triton X-100, pH 169 
8.0, supplemented with EDTA-free protease inhibitor cocktail, Roche) were 170 
determined using the BCA Protein Assay Kit (Pierce, Thermo Scientific), and 10 μg 171 
of total protein was loaded for each lane. Sample preparation for SDS-PAGE and 172 
immunoblotting as well as the probing and detection of immunoblots using the anti-173 
rNP PAb (affinity purified from anti-UHV serum, used at 0.1 μg/ml concentration) 174 
were as described (10). The HRP-labelled anti-rNP-N and anti-rNP-C PAb were used 175 
at 0.25 μg/ml to 0.1 μg/ml concentrations diluted in blocking buffer (50 mM Tris, 150 176 
mM NaCl, 0.05% Tween 20, pH 8.0) with 3% skimmed milk powder. The results 177 
were recorded on X-ray film (Fuji Medical RX) utilizing in-house ECL reagents. 178 
Quantitative PCR (qPCR). 179 
Total RNA was isolated from UHV-infected boid cells grown at different 180 
temperatures with the RNeasy Mini Kit (Qiagen) according to the manufacturer’s 181 
protocol. For RNA quantification 1 μg total RNA was transcribed to cDNA, using 182 
RevertAid Premium Reverse Transcriptase (Thermo Scientific) following the 183 
manufacturer’s protocol. An equal amount of cDNA from each sample was used as 184 
template for real-time PCR (Stratagene MX3500P) amplification of UHV L-segment 185 
RNA (primer sequences targeting the Z protein region, originally designed for 186 
cloning, Forward: 5'-CATATGAGCGAATCAACCGCAATAGGTC-3' and Reverse: 187 
5'-CTCGAGTGGT TCGGGGAGG-3'), with Maxima SYBR Green qPCR Master 188 
Mix (Thermo Scientific). The relative amount of viral RNA was estimated based on 189 
Ct differences as compared to the lowest Ct observed (UHV grown at 37°C).  190 
Histological, immunohistochemical (IHC), immunofluorescence (IF) and 191 
transmission electron microscopy (TEM) examinations. 192 
For histology and IHC, cultured cells were detached by trypsination and pelleted by 193 
centrifugation (2,850 x g, 3 min, RT), then fixed in 2.5% paraformaldehyde (PFA) in 194 
0.2 M phosphate-buffered saline (PBS, pH 7.4) for 24 h at 5°C and routinely paraffin 195 
wax embedded. Sections (3-5 µm) were prepared and either stained with 196 
hematoxylin-eosin (HE) and examined for the presence of BIBD IB, or used for IHC. 197 
Briefly, for IHC, after antigen retrieval with citrate buffer (pH 6.0) in a microwave 198 
oven, sections were incubated with affinity-purified rabbit anti-UHV NP (0.25 μg/ml 199 
in PBS), followed by HRP-labeled goat anti-rabbit antibody (UltraVision anti-rabbit 200 
HRP detection system, Thermo Scientific), with subsequent visualization with 201 
diaminobenzidintetrahydrochloride (DAB) and hematoxylin counterstaining as 202 
described (10).  203 
Histological and IHC examinations were performed on pellets from two culture flasks 204 
for each test in a semi-quantitative fashion. In each complete pellet section (400 x 205 
magnification), the proportion of cells with one or more intracytoplasmic IB was 206 
graded in 10% steps. The IB size was assessed in µm diameter. Viral NP protein 207 
expression was seen in association with IB and, as a more diffuse, but distinct 208 
cytoplasmic reaction. Based on the staining intensity within positive cells and the 209 
proportion of positive cells, the IHC reaction was graded on a scale from 0.5 to 3, 210 
corresponding to a faint (0.5), weak (1), weak to moderate (1.5), moderate (2), 211 
moderate to strong (2.5) or strong (3) overall staining intensity. Subsequently, IHC 212 
reaction and histology score were combined as indicator of the presence and extent of 213 
arenavirus infection in the culture. Scoring was undertaken three times by the same 214 
investigator (UH) in a blind fashion. 215 
For TEM, cells were scraped from the flasks and pellets prepared as above, fixed in 216 
1.5% glutaraldehyde buffered in 0.2 M cacodylic acid buffer, pH 7.3, for 12 h at 5°C, 217 
and routinely embedded in epoxy resin. Semi-thin and thin sections were prepared as 218 
previously described (10), and the latter were examined for the presence and 219 
morphology of BIBD IB, using a Philips CM 100.  220 
For IF, cells were grown and infected either on diagnostic 10-well slides, or in culture 221 
vessels, detached by pipetting (tick cells) or by trypsinization (vertebrate cells), 222 
washed with PBS, diluted in PBS and dried on slides. After fixation in acetone for 10 223 
min, slides were incubated with the anti-NP and anti-NP-C antibodies diluted in PBS 224 
(0.25 μg/ml to 0.5 μg/ml), followed by Alexa Fluor 488-labeled or Alexa Fluor 555-225 
labeled goat anti-rabbit (both 1:1,500 dilution in PBS; Invitrogen) for visualization. 226 
227 
RESULTS 228 
Expression and purification of recombinant UHV NP. 229 
We recently characterized two rabbit antisera raised against UHV purified from cell 230 
cultures of boid cells (10). Both antisera reacted also with proteins of boid cells which 231 
prompted us to produce and purify protein specific antibodies. For this purpose, we 232 
produced UHV NP (rNP, aa 1-582), the N-terminal portion of NP (rNP-N, aa 1-339), 233 
and the C-terminal portion of NP (rNP-C aa 346-582) with a histidine-tag, using a 234 
baculovirus expression system. Immobilized-metal affinity chromatography (IMAC) 235 
under denaturing conditions served to purify the proteins, and SDS-PAGE and 236 
immunoblotting with anti-his antibody for estimating the purity of the preparations 237 
(Fig. 1, top left and middle panel). While rNP and rNP-C each yielded a single 238 
distinct band, rNP-N produced a triplet band of the approximate expected molecular 239 
size. It is likely that the triplet band is the result of either secondary modifications 240 
(e.g. phosphorylation) or N-terminally fragmented pieces of the desired product (his-241 
tag is located in the C-terminus), since all bands of the triplet were recognized by the 242 
anti-his antibody (Fig. 1, top middle panel).  243 
The rNP coupled to CnBr Sepharose was used to affinity purify anti-NP PAb from 244 
antiserum produced against UHV (10), and NP specific PAbs from antisera produced 245 
against rNP-N and rNP-C. The anti-NP reacted strongly with infected cell lysates and 246 
rNP, and rNP-C elicited a much stronger immunoreaction than rNP-N (Fig. 1, top 247 
right panel), indicating epitope predominance in the C-terminus of NP. The PAbs 248 
purified from rNP-N and rNP-C antisera were further labelled with HRP to facilitate 249 
the direct use in downstream assays. Both anti-rNP-N and anti-tNP-C were found to 250 
react with NP from infected cells and with rNP (Fig. 1, lower panels). Both anti-rNP-251 
N weakly reacted with rNP-C and vice versa (Fig. 1, lower panels), most probably 252 
due to the presence of his-tag in both proteins.  253 
UHV infects cells at 30˚C but growth is limited or hindered at 37˚C.  254 
In our recent paper we demonstrated that UHV not only grows in boid cells, but can 255 
also infect and be adapted to grow in Vero E6 cells (10). Initial attempts at infecting 256 
the cells with UHV under standard culturing conditions (5% CO2, 37˚C) had been 257 
unsuccessful, whereas maintenance under conditions similar to those applied to the 258 
boid cells (10), i.e. at ambient temperatures between 27˚C and 30˚C, resulted in 259 
accumulation of UHV antigens. We thus infected both boid kidney and Vero E6 cells 260 
with UHV (both Vero E6- and boa cell-adapted UHV), incubated the cells at either 261 
30˚C or 37˚C, and monitored the virus growth by immunoblotting to detect the 262 
accumulation of NP. When grown at 30˚C, both cell lines express NP already 2 days 263 
post infection (dpi), whereas no NP is detected in cells grown at 37˚C (Fig. 2), 264 
indicating that growth is inhibited or markedly hindered at the higher temperature.  265 
Productive UHV infection is reflected in presence, size and quantity of inclusion 266 
bodies and viral NP expression. 267 
A specific feature of BIBD is the formation of variably sized eosinophilic 268 
intracytoplasmic IB (10). To further characterize the IB, to establish their 269 
requirements for active replication, and to assess whether adaptation to Vero E6 cells 270 
impairs the ability of UHV to infect boid cells, we collected boid and Vero E6 cells 271 
infected with boa- and Vero E6-adapted UHV (boa-UHV and Vero-UHV, 272 
respectively) at 8 dpi and analysed them both light microscopically (histology, IF, 273 
IHC) and ultrastructurally (TEM). The most relevant quantitative results are 274 
summarised in Table 1. 275 
Regardless of the ambient temperature, boid kidney cells infected with boa-UHV 276 
exhibited variably sized (0.5 -3.5 µm) IB in a moderate proportion (up to 40%) of 277 
cells, whereas viral NP expression was obvious in more than 50% of the cells, with an 278 
overall weak to moderate expression intensity (Fig.3A). When consistently 279 
maintained at 30°C Vero-UHV induced a more intense infection in the boid cells (up 280 
to 80% NP-positive cells and moderate NP expression intensity; Fig. 3B). In contrast, 281 
incubation at 37°C reduced both the proportion of cells with IB and the degree of NP 282 
expression. This was most pronounced in cells consistently maintained at 37°C, when 283 
IB were often barely visible and only faint NP expression confirmed infection of the 284 
cells (Fig. 3C; Table 1). The results show that both boa- and Vero-UHV can 285 
productively infect boid cells. However, once the virus is adapted to Vero E6 cells, its 286 
replication capacity appears to decline with an increase in ambient temperature. 287 
At a consistent ambient temperature of 30°C, Vero-UHV yielded similar results in 288 
Vero E6 cells as boa-UHV in boid kidney cells (up to 40% cells with IB of 0.5 - 3.0 289 
µm diameter, moderate NP expression in up to 40% of cells; Fig. 3D). Boa- UHV 290 
infected the Vero E6 cells at 30°C, but with low efficiency, since no more than 20% 291 
of cells had developed IB at 8 dpi, and NP was only weakly expressed (Fig. 3E). 292 
Incubation at 37°C for any length of time resulted in an even lower efficiency of 293 
infection (Table 1). Interestingly, the infection with Vero-UHV seemed to fail when 294 
the cells were incubated at 37°C immediately after infection (Table 1). These findings 295 
suggest that adaptation of UHV to Vero E6 cells is associated with loss of its capacity 296 
to infect and grow in these cells at 37°C, perhaps through selection during adaptation.   297 
The ultrastructural characteristics of the IB were very similar irrespective of the 298 
infected cell line or the virus isolate used when cells were grown at 37°C (Fig 4). The 299 
kinetics of IB formation appeared to be similar in both cell lines. At 8 dpi, the 300 
majority of IB were of irregular shape. By 12 dpi, they had acquired the round to 301 
ovoid shape of the IB typically seen in cells of boids with BIBD (10). At this stage, 302 
the number of IB overall appeared to be lower than at 8 dpi (data not shown). 303 
Exposure of infected cells to higher ambient temperatures leads to a decrease in 304 
the amount of NP. 305 
Since growth of UHV was found to be impaired at 37˚C, we decided to more closely 306 
investigate the effect of a temperature rise to 37˚C on cells infected and initially 307 
grown at 30˚C. We therefore passaged UHV-infected cells at 15 dpi (boid cells) and 308 
12 dpi (Vero E6 cells) and incubated the new plates at either 30˚C or 37˚C. UHV 309 
replication was monitored at 2-day intervals by quantifying the amount of UHV NP in 310 
cells using immunoblotting. The temperature increase to 37˚C was associated with a 311 
gradual, time-dependent decrease in the amount of UHV NP in cells, indicating that 312 
the higher temperature adversely affected the replication of UHV (Fig. 5A). The 313 
observed decrease in NP also indicates that the cells lose the accumulated NP deposits 314 
likely through the normal cell turnover, since cytopathic effects were not seen. This 315 
would suggest that the IB are indeed dynamic complexes, and essential for replication 316 
(13).  317 
To analyse whether the decrease in NP would be due to impaired replication of the 318 
virus, we compared the amount of viral RNA (both genomic and anti-genomic) after 319 
incubation at different temperatures. We infected boid cells with boa-UHV, incubated 320 
them at 30˚C or 37˚C for 5 d, and then transferred a plate of cells grown at 30˚C to 321 
37˚C, and vice versa. Cells maintained at 30˚C and 37˚C for the entire examination 322 
period served as controls. Samples collected daily up to 8 dpi were analysed by qPCR 323 
using UHV Z protein-specific primers which showed that UHV replication is 324 
dramatically reduced at 37˚C (Fig. 5B); however, when such cells were transferred to 325 
30˚C after 5 d, replication restarted. When cells grown at 30˚C were transferred to 326 
37˚C, the amount of viral RNA decreased; interestingly, the amount of viral RNA 327 
started to increase again after 4 d at the higher temperature, after the initial decrease 328 
but at levels approximately 20-40 times lower than in cells grown at 30˚C. Despite the 329 
modest recovery of RNA levels (Fig 5B), no protein expression was seen in cells 330 
grown at 37˚C (Fig. 2).  331 
UHV originates from a chronically-infected boid bone marrow cell line passaged for 332 
more than 10 years at temperatures between 27˚C and 30˚C (10). Therefore, in order 333 
to exclude previous cell culture adaptation to a specific temperature range, we decided 334 
to study the temperature preference of a recently isolated, genetically distant, 335 
BIBDAV (T10404; from snake no. 5 in (10)). We infected both Vero E6 and boid 336 
cells with T10404 and maintained the cultures at 30˚C or 37˚C; at 4 dpi we performed 337 
temperature swaps and monitored virus growth in samples collected at 5, 7, and 9 dpi 338 
as above. The progressive decline in the amount of NP indicates that also the 339 
replication of T10404 is impaired in both cell types at 37˚C (Fig. 5C, lanes 2, 5 and 8) 340 
in comparison to cells grown at 30˚C (Fig. 5C, lanes 1, 4 and 7). Different from the 341 
Vero E6 cells, boid cells inoculated with the virus at 37˚C started to produce virus 342 
once transferred to 30˚C (Fig. 5C, lanes 3, 6 and 9), suggesting that, similar to UHV, 343 
T10404 retains its infectivity and/or replicates at a low level in boid cells at a higher 344 
temperature.  345 
UHV infects cells from different animal classes.  346 
To further investigate the potential of BIBDAV to infect cells other than boid and 347 
non-human primate cells (Vero E6), we infected a range of cell lines originating from 348 
different animal classes (mammalian, arthropod) with UHV. We wanted to test 349 
replication of BIBDAV in arthropod cells, since BIBD epidemics are often 350 
concomitant with snake mite infestation (25), and snake mites could act as a vector 351 
for BIBDAV. Since mite cells are not available, we used tick cell lines instead. We 352 
found evidence of UHV growth (NP production) by both IF (Fig. 6A) and 353 
immunoblots (Fig. 6B) in both mammalian (Vero, Vero E6, A549 and BHK-21) and 354 
arthropod (tick cell lines RAE/CTVM1 from R. appendiculatus, IRE/CTVM19 from 355 
I. ricinus, and BME/CTVM2 from R. (B.) microplus) cells when they were 356 
propagated at 30˚C, indicating that these cells are permissive for UHV. Curiously, 357 
also human cells were found permissive for UHV previously propagated in boid but 358 
not in Vero E6 cells. These results highlight the potential of arenaviruses to cross 359 
species barriers.   360 
DISCUSSION 361 
BIBD is a fatal disease of boid snakes that is morphologically characterized by the 362 
formation of typical intracytoplasmic IB. Recent studies have provided convincing 363 
evidence that arenaviruses are the causative agents of BIBD; however, the reservoir 364 
host of BIBDAV - if any host exists besides boid snakes themselves - is still 365 
unknown. For classical arenaviruses the known reservoir hosts are mammals, i.e. 366 
rodents, and for one arenavirus (Tacaribe virus) a bat (4). The isolation of BIBDAV 367 
from and in cells of a different taxonomic class, reptiles, i.e. snakes, suggested that 368 
arenaviruses might have considerable ability to cross species barriers (10). With this 369 
in mind we tested UHV for its ability to infect a panel of cell lines from mammalian 370 
and arthropod species, and herein report that BIBDAV can indeed infect cells of 371 
various animal classes. Furthermore, we demonstrate that the replication of BIBDAV 372 
is temperature-sensitive regardless of the cell type and virus strain used. 373 
The fact that BIBDAV, which like all other arenaviruses in their hosts, cause systemic 374 
infections in the snakes, replicate effectively at 30˚C but less or not at all at 37˚C 375 
indicates that the body temperature of the reservoir host of these viruses is lower than 376 
37˚C. Mammals are endothermic with body temperatures close to 37˚C except when 377 
hibernating, suggesting that the BIBDAV reservoir hosts might not be mammals. In 378 
contrast, snakes are exothermic and can therefore provide a suitable ambient 379 
temperature range to promote the effective growth of BIBDAV. Captive boid snakes 380 
are commonly housed under controlled temperature conditions (typically 25°C at 381 
night and 27-31˚C during the day), which we have shown would support the 382 
replication of BIBDAV. This could explain the high susceptibility of captive boids to 383 
these viruses. In contrast, wild snakes are exposed to a broader range of temperatures, 384 
and in the case of boids and other snakes known to develop BIBD these are often 385 
higher. Our findings thus suggest that in wild snakes the replication of BIBDAV 386 
could be restricted or influenced by changes in the ambient temperature, and that the 387 
susceptibility of a snake species might actually be related to the environment in which 388 
it lives. Chronic infection of the reservoir host is seen with “classical” rodent-borne 389 
arenaviruses, and is considered almost a hallmark of the family Arenaviridae. 390 
Accordingly, BIBDAV could chronically infect boids living in the wild, however, to 391 
our knowledge there is so far no report suggesting this.  392 
The occurrence of BIBD in snake collections has been associated with concurrent 393 
snake mite (Ophionyssus natricis) infestation (25). Since cell lines of this arthropod 394 
species are not available, we tested embryo-derived cell lines of three tick species, I. 395 
ricinus R. appendiculatus and R. (B.) microplus, for their susceptibility to UHV. 396 
Indeed, all three tick cell lines were found to support UHV replication, which 397 
provides the first evidence that BIBDAV could indeed be transmitted by an arthropod 398 
vector, i.e. be an arbovirus, with arthropods acting as intermediate or even as reservoir 399 
hosts for BIBDAV. This hypothesis is supported by the fact that other arthropod-400 
borne viruses, i.e. members of the Togaviridae and Flaviviridae, have been found in 401 
snakes (26), and arthropods such as ticks and mosquitoes can harbour persistent 402 
arbovirus infections in the absence of obvious deleterious effects (27-29). On the 403 
other hand, LCMV, another arenavirus, has been shown to productively infect 404 
primary tick cell cultures (30), which indicates that tick cells are in general permissive 405 
for arenaviruses. Transmission via an arthropod vector would allow BIBDAV, at least 406 
in theory, to cross from one host species to another in the wild. It remains to be 407 
studied whether snake mites or other blood-sucking parasites, such as ticks, can 408 
indeed transmit the virus.  409 
The fact that UHV was able to infect such a broad range of cell lines, and that UHV 410 
was still able to infect boid cells after it was adapted to Vero E6 cells through 411 
cultivation, is particularly interesting with regards to its potential receptor usage. 412 
Curiously, Vero-UHV infected A549 cells with lower efficacy than boa-UHV. Vero 413 
E6 cells are known to secrete interferon-lambda (IFN-λ) in response to infection by 414 
New World hantaviruses (31). Thus the observed growth restriction of Vero-UHV in 415 
A549 cells might be due to inhibitory effects of IFN-λ. As few tools are available for 416 
detecting boid proteins or genes, the infection of Vero E6 and A549 cells will 417 
facilitate studies on, for example, the interaction of BIBDAV with receptors and 418 
innate immunity. Rodent-borne arenaviruses use transferrin receptor 1 (TfR1) and α-419 
dystroglycan as their receptors when infecting man (32, 33). A549 cells are known to 420 
express TfR1 and therefore it is of interest to determine whether BIBDAV would use 421 
this receptor for their entry. Thus far, nothing is known about the cellular receptor(s) 422 
of BIBDAV. However, the ability of UHV to infect various cell lines, and the fact that 423 
in snakes with BIBD develop IB in basically all cell types, suggests that the receptor 424 
is more or less ubiquitous and conserved throughout animal classes. This would, again 425 
in theory, enable the spread of BIBDAV to different classes of animals. Nevertheless, 426 
it appears that the spread of these viruses is limited by their growth temperature 427 
requirements.  428 
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FIGURE LEGENDS 559 
Figure 1. UHV recombinant proteins. The top left panel shows recombinant NP 560 
(rNP), rNP-N (N-terminal fragment of NP, aa 1-339) and rNP-C (C-terminal fragment 561 
of NP, aa 346-582) IMAC-purified under denaturing conditions as separated by SDS-562 
PAGE and visualized by Coomassie Brilliant Blue staining. The top middle and right 563 
panels show immunoblots with anti-His tag and affinity purified anti-UHV NP 564 
antibodies respectively. Bottom left and right panels show immunoblots with affinity 565 
purified anti-rNP-N and anti-rNP-C antibodies, respectively. The immunoblots were 566 
visualized by Odyssey Infrared Imaging System (LI-COR). 567 
Figure 2. Temperature restricts BIBDAV growth in boid and Vero E6 cells. Boid and 568 
Vero E6 cells were infected with Vero-UHV and cultured at 30 ˚C or 37 ˚C. Cells 569 
were collected in lysis buffer and 10 μg of total protein from each time point was 570 
analysed by immunoblotting using HRP-labelled anti-rNP-C antibody. The results 571 
were recorded on X-ray film utilizing ECL.  572 
Figure 3. Morphological features and BIBDAV NP expression in UHV-infected cell 573 
cultures at 8 dpi. A-C) Permanent cell line I/1Ki derived from boid kidney cells. A) 574 
Infection with boa-UHV and incubation at 30°C. Viral NP expression is observed in 575 
more than 50% of the cells, with an overall weak to moderate staining intensity. NP 576 
expression is also seen in the inclusion bodies (arrows); inset: variably sized inclusion 577 
bodies as evident in HE stained sections (arrowheads). B) Infection with Vero-UHV 578 
and incubation at 30°C. Around 80% of cells exhibit NP expression, and with overall 579 
moderate staining intensity. C) Cells maintained at 37°C for 8 d. NP expression is 580 
mainly seen as a faint diffuse cytoplasmic staining in a few cells (arrows) or, rarely, 581 
as very small cytoplasmic inclusion bodies (arrowhead; score 0.5; D, E). African 582 
Green Monkey (Vero E6) cells after UHV infection and culture at 30°C for 8 d. D) 583 
Infection with Vero-UHV. Viral NP expression is observed in approximately 40% of 584 
the cells, with an overall moderate staining intensity. NP Inset: variably sized 585 
inclusion bodies as evident in HE stained sections (arrowheads). E) Infection with 586 
boa-UHV results in the formation of small IB that are only visible when stained for 587 
NP expression (arrows); NP expression is seen in less than 20% of cells, and with 588 
generally weak intensity. HRP method, hematoxylin counterstain, Bars = 20 µm; 589 
insets: HE stain. 590 
Figure 4. Ultrastructural features of boid kidney cells cells (A: mock infected; B: boa-591 
UHV infected) and Vero E6 cells (C: mock infected; D; Vero-UHV infected). Cells 592 
were maintained at 30°C for 8 dpi. In boid kidney cells (B), IB appear as several 593 
irregularly shaped intracytoplasmic structures (arrows). In the Vero E6 cells (D), they 594 
are round to ellipsoid (arrows). Bars = 2 µm. 595 
Figure 5. The effect of ambient temperature on the growth of UHV and T10404. A) 596 
Boid and Vero E6 cells infected with UHV (15 dpi and 12 dpi, respectively) were 597 
transferred to fresh 6-well plates and grown at 30˚C or 37˚C. Cells were collected at 598 
two day interval in lysis buffer and 10 μg of total protein from each time point was 599 
analysed by immunoblotting using HRP-labelled anti-rNP-C antibody. The results 600 
were recorded on X-ray film utilizing ECL. B) Boid cells were infected with UHV 601 
and grown at 30˚C or 37˚C. At 5 dpi a plate of cells grown at 37˚C was transferred to 602 
30˚C and a plate of cells grown at 30˚C to 37˚C. Infected cells constantly kept at 30˚C 603 
or 37˚C were used as controls. RNA isolated from cells collected at 5, 6, 7, and 8 dpi 604 
(x-axis) was quantified with qPCR using UHV Z protein-specific primers. The results 605 
are shown as fold increase in comparison to the vRNA level of cells grown at 37˚C (2 606 
dpi, the highest Ct value measured). C) Boid and Vero E6 cells were infected with 607 
T10404 and cultured at 30˚C or 37˚C. At 4 dpi the cells grown at 37˚C were 608 
transferred to 30˚C (37˚C=>30˚C), and a plate of cells grown at 30˚C was transferred 609 
to 37˚C (30 ˚C=>37˚C). Infected cells kept constantly at 30˚C were used as positive 610 
controls. Cells were collected in lysis buffer and 10 μg of total protein from each time 611 
point was analysed by immunoblotting using affinity purified anti-UHV NP antibody 612 
(anti-rNP-N and anti-rNP-C yielded lower signal intensity). The immunoblot was 613 
recorded using Odyssey Infrared Imaging System (LI-COR). 614 
Figure 6. Susceptibility of different cell lines to UHV infection. BME/CTVM2 (R. 615 
[B.] microplus embryo), RAE/CTVM1 (R. appendiculatus embryo), IRE/CTVM19 (I. 616 
ricinus embryo) BHK-21 (baby hamster kidney), Vero (African green monkey 617 
kidney), and A549 (human lung adenocarcinoma) cells were infected with UHV and 618 
grown at 30˚C. A) Infected (UHV) and non-infected (mock) cells were fixed (at 8 dpi 619 
for BHK and Vero, 14 dpi for tick cell lines, and 3 dpi for A549) and stained with 620 
anti-rNP-C polyclonal antibody in conjugation with anti-rabbit AlexaFluor 488-621 
labeled secondary antibody. The cells were imaged at 400x magnification. B) 622 
Immunoblot of UHV-infected tick and BHK21-cells on left panel and A549 cells on 623 
right panel. The cells were collected (at 8 dpi for BHK, 14 dpi for tick cell lines, and 624 
at 1 and 3 dpi for A549) in lysis buffer and 10 μg of total protein analysed by 625 
immunoblotting with affinity purified anti-UHV NP antibody as recorded by Odyssey 626 
Infrared Imaging System (LI-COR). 627 
  628 
Table 1.   Results of the semi-quantitative assessment of BIBDAV infection of boid kidney 629 
and Vero E6 cells with boa- and Vero-UHV maintained at different ambient temperatures for 630 
8 days, based on the proportion of cells with IB and the extent of in situ NP expression. 631 
Cell 
type 
Virus used 30°C (8d) 30°C (4d) → 37°C (4d) 37°C (8d) 37°C (4d) → 30°C (4d)
N (%) IHC N (%) IHC N (%) IHC N (%) IHC
Boid 
kidney 
Boa-UHV > 30 - 40 1.5 > 30 - 40 1.5 > 30 - 40 1.0 > 20 - 30 1.0
Vero-UHV > 40 - 50 2.0 > 10 - 20 1.5 ≤ 10 0.5 > 20 - 30 1.0
Vero E6 Boa-UHV > 10 - 20 1.0 ≤ 10 0.5 ≤ 10 0.5 ≤ 10 0.5
Vero-UHV > 30 - 40 2.0 ≤ 10 1.0 - - - -
 632 
Scoring based on: N - percentage of cells with IB. IHC - in situ, i.e. immunohistochemical 633 
expression of BIBDAV NP antigen, graded as faint (0.5), weak (1), weak to moderate (1.5), 634 
moderate (2), moderate to strong (2.5) and strong (3) based on the staining intensity within 635 
positive cells and the proportion of positive cells. 636 
Figure 1. UHV recombinant proteins. The top left panel shows recombinant NP (rNP), rNP-N (N-
terminal fragment of NP, aa 1-339) and rNP-C (C-terminal fragment of NP, aa 346-582) IMAC-
purified under denaturing conditions as separated by SDS-PAGE and visualized by Coomassie
Brilliant  Blue  staining.  The  top  middle  and  right  panels  show immunoblots  with  anti-His  tag  and
affinity purified anti-UHV NP antibodies respectively. Bottom left and right panels show
immunoblots with affinity purified anti-rNP-N and anti-rNP-C antibodies, respectively. The
immunoblots were visualized by Odyssey Infrared Imaging System (LI-COR).
Figure 2. Temperature restricts BIBDAV growth in boid and Vero E6 cells. Boid and Vero E6 cells
were infected with Vero-UHV and cultured at 30 ˚C or 37 ˚C. Cells were collected in lysis buffer
and 10 mg of total protein from each time point was analysed by immunoblotting using HRP-
labelled anti-rNP-C antibody. The results were recorded on X-ray film utilizing ECL.
Figure 3. Morphological features and BIBDAV NP expression in UHV-infected cell cultures at 8
dpi. A-C) Permanent cell line I/1Ki derived from boid kidney cells. A) Infection with boa-UHV and
incubation at 30°C. Viral NP expression is observed in more than 50% of the cells, with an overall
weak to moderate staining intensity. NP expression is also seen in the inclusion bodies (arrows);
inset: variably sized inclusion bodies as evident in HE stained sections (arrowheads). B) Infection
with Vero-UHV and incubation at 30°C. Around 80% of cells exhibit NP expression, and with
overall moderate staining intensity. C) Cells maintained at  37°C for 8 d.  NP expression is mainly
seen  as  a  faint  diffuse  cytoplasmic  staining  in  a  few  cells  (arrows)  or,  rarely,  as  very  small
cytoplasmic inclusion bodies (arrowhead; score 0.5; D, E). African Green Monkey (Vero E6) cells
after UHV infection and culture at 30°C for 8 d. D) Infection with Vero-UHV. Viral NP expression
is observed in approximately 40% of the cells, with an overall moderate staining intensity. NP Inset:
variably sized inclusion bodies as evident in HE stained sections (arrowheads). E) Infection with
boa-UHV results in the formation of small IB that are only visible when stained for NP expression
(arrows); NP expression is seen in less than 20% of cells, and with generally weak intensity. HRP
method, hematoxylin counterstain, Bars = 20 µm; insets: HE stain.
Figure 4. Ultrastructural features of boid kidney cells cells (A: mock infected; B: boa-UHV
infected) and Vero E6 cells (C: mock infected; D; Vero-UHV infected). Cells were maintained at
30°C for 8 dpi.  In boid kidney cells (B), IB appear as several irregularly shaped intracytoplasmic
structures (arrows). In the Vero E6 cells (D), they are round to ellipsoid (arrows). Bars = 2 µm.
Figure 5. The effect of ambient temperature on the growth of UHV and T10404. A) Boid and Vero
E6 cells infected with UHV (15 dpi and 12 dpi, respectively) were transferred to fresh 6-well plates
and grown at  30˚C or 37˚C. Cells were collected at  two day interval in lysis buffer and 10 mg of
total protein from each time point was analysed by immunoblotting using HRP-labelled anti-rNP-C
antibody. The results were recorded on X-ray film utilizing ECL. B) Boid cells were infected with
UHV and grown at 30˚C or 37˚C. At 5 dpi a plate of cells grown at 37˚C was transferred to 30˚C
and a plate of cells grown at 30˚C to 37˚C. Infected cells constantly kept at 30˚C or 37˚C were used
as  controls.  RNA  isolated  from  cells  collected  at  5,  6,  7,  and  8  dpi  (x-axis)  was  quantified  with
qPCR using UHV Z protein-specific primers. The results are shown as fold increase in comparison
to the vRNA level of cells grown at 37˚C (2 dpi, the highest Ct value measured). C) Boid and Vero
E6 cells were infected with T10404 and cultured at 30˚C or 37˚C. At 4 dpi the cells grown at 37˚C
were transferred to 30˚C (37˚C=>30˚C), and a plate of cells grown at 30˚C was transferred to 37˚C
(30 ˚C=>37˚C). Infected cells kept constantly at 30˚C were used as positive controls. Cells were
collected in lysis buffer and 10 mg  of  total  protein  from  each  time  point  was  analysed  by
immunoblotting using affinity purified anti-UHV NP antibody (anti-rNP-N and anti-rNP-C yielded
lower signal intensity). The immunoblot was recorded using Odyssey Infrared Imaging System (LI-
COR).
Figure 6. Susceptibility of different cell lines to UHV infection. BME/CTVM2 (R. [B.] microplus
embryo),  RAE/CTVM1  (R. appendiculatus embryo),  IRE/CTVM19  (I. ricinus embryo) BHK-21
(baby hamster kidney), Vero (African green monkey kidney), and A549 (human lung
adenocarcinoma) cells were infected with UHV and grown at 30˚C. A) Infected (UHV) and non-
infected (mock) cells were fixed (at 8 dpi for BHK and Vero, 14 dpi for tick cell lines, and 3 dpi for
A549) and stained with anti-rNP-C polyclonal antibody in conjugation with anti-rabbit AlexaFluor
488-labeled secondary antibody. The cells were imaged at 400x magnification. B) Immunoblot of
UHV-infected  tick  and  BHK21-cells  on  left  panel  and  A549  cells  on  right  panel.  The  cells  were
collected (at 8 dpi for BHK, 14 dpi for tick cell lines, and at 1 and 3 dpi for A549) in lysis buffer
and 10 mg of total protein analysed by immunoblotting with affinity purified anti-UHV NP antibody
as recorded by Odyssey Infrared Imaging System (LI-COR).
